Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development

Journal of Pathology

Volumn 241, Issue 3, 2017, Pages 392-404

  Zhang, Weigang ^a   Guo, Sen ^a   Li, Bing ^a   Liu, Lin ^a   Ge, Rui ^a   Cao, Tianyu ^a   Wang, Huina ^a   Gao, Tianwen ^a   Wang, Gang ^a   Li, Chunying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

HMGB1; IL 18; imiquimod; inflammasome; keratinocyte; NF B; psoriasis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; RECOMBINANT HIGH MOBILITY GROUP PROTEIN B1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; HMGB1 PROTEIN, HUMAN; HMGB1 PROTEIN, MOUSE; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TH17 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; ANIMALS; AUTOCRINE COMMUNICATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; HUMANS; INFLAMMASOMES; INTERLEUKIN-17; INTERLEUKIN-18; KERATINOCYTES; MICE, INBRED BALB C; PSORIASIS; SIGNAL TRANSDUCTION;

EID: 85007048830     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4848     Document Type: Article

References (66)

1. Boehncke WH, Schon MP. Psoriasis. Lancet 2015; 386: 983–994.
2. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Annu Rev Pathol 2012; 7: 385–422.
3. Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014; 32: 227–255.
4. Yan S, Xu Z, Lou F, et al. NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun 2015; 6: 7652.
5. Winge MC, Ohyama B, Dey CN, et al. RAC1 activation drives pathologic interactions between the epidermis and immune cells. J Clin Invest 2016; 126: 2661–2677.
6. Shi X, Jin L, Dang E, et al. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. J Invest Dermatol 2011; 131: 2401–2408.
7. Malarkey CS, Churchill ME. The high mobility group box: the ultimate utility player of a cell. Trends Biochem Sci 2012; 37: 553–562.
8. Scovell WM. High mobility group protein 1: a collaborator in nucleosome dynamics and estrogen-responsive gene expression. World J Biol Chem 2016; 7: 206–222.
9. Kang R, Chen R, Zhang Q, et al. HMGB1 in health and disease. Mol Aspects Med 2014; 40: 1–116.
10. Tsung A, Tohme S, Billiar TR. High-mobility group box-1 in sterile inflammation. J Intern Med 2014; 276: 425–443.
11. Bergmann C, Strohbuecker L, Lotfi R, et al. High mobility group box 1 is increased in the sera of psoriatic patients with disease progression. J Eur Acad Dermatol Venereol 2016; 30: 435–441.
12. Chen T, Guo ZP, Li L, et al. Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris. Arch Dermatol Res 2013; 305: 263–267.
13. Borkowski AW, Gallo RL. UVB radiation illuminates the role of TLR3 in the epidermis. J Invest Dermatol 2014; 134: 2315–2320.
14. Meisgen F, Xu Landen N, Wang A, et al. MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. J Invest Dermatol 2014; 134: 1931–1940.
15. Jacquet A. The role of innate immunity activation in house dust mite allergy. Trends Mol Med 2011; 17: 604–611.
16. Riol-Blanco L, Ordovas-Montanes J, Perro M, et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 2014; 510: 157–161.
17. Park HS, Kim EN, Kim MY, et al. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice. Transpl Immunol 2016; 34: 42–49.
18. Yu S, Chen Z, Mix E, et al. Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen. J Neuropathol Exp Neurol 2002; 61: 614–622.
19. Harandi AM, Svennerholm B, Holmgren J, et al. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J Virol 2001; 75: 6705–6709.
20. Andersson U, Antoine DJ, Tracey KJ. The functions of HMGB1 depend on molecular localization and post-translational modifications. J Intern Med 2014; 276: 420–424.
21. Pietrzak A, Lecewicz-Torun B, Chodorowska G, et al. Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score. Acta Derm Venereol 2003; 83: 262–265.
22. Companjen A, van der Wel L, van der Fits L, et al. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions. Eur Cytokine Netw 2004; 15: 210–216.
23. Flisiak I, Klepacki A, Chodynicka B. Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity. Biomarkers 2006; 11: 194–200.
24. Andres RM, Hald A, Johansen C, et al. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity. Exp Dermatol 2013; 22: 323–328.
25. Hald A, Andres RM, Salskov-Iversen ML, et al. STAT1 expression and activation is increased in lesional psoriatic skin. Br J Dermatol 2013; 168: 302–310.
26. Yanai H, Ban T, Taniguchi T. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol 2012; 33: 633–640.
27. Zhang M, Guo Y, Fu H, et al. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFkappaB/IL-1beta signaling. Cell Death Dis 2015; 6: e1847.
28. Zhang Y, Zhu T, Zhang X, et al. Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes. J Neuroinflammation 2015; 12: 156.
29. van de Veerdonk FL, Netea MG, Dinarello CA, et al. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011; 32: 110–116.
30. Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell 2016; 165: 792–800.
31. Novick D, Kim S, Kaplanski G, et al. Interleukin-18, more than a Th1 cytokine. Semin Immunol 2013; 25: 439–448.
32. Blom L, Poulsen LK. IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures. J Immunol 2012; 189: 4331–4337.
33. Cross AS. IL-18/IL-1/IL-17A axis: a novel therapeutic target for neonatal sepsis? Cytokine 2016; 86: 1–3.
34. Harrison OJ, Srinivasan N, Pott J, et al. Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3(+) Treg cell function in the intestine. Mucosal Immunol 2015; 8: 1226–1236.
35. Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 2016; 50: 377–389.
36. Dejean E, Foisseau M, Lagarrigue F, et al. ALK + ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-kappaB activation. Blood 2012; 119: 4698–4707.
37. Sinagra T, Merlo S, Spampinato SF, et al. High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes. Front Pharmacol 2015; 6: 126.
38. Shin JU, Noh JY, Lee JH, et al. In vivo relative quantitative proteomics reveals HMGB1 as a downstream mediator of oestrogen-stimulated keratinocyte migration. Exp Dermatol 2015; 24: 478–480.
39. Galbiati V, Papale A, Galli CL, et al. Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes. J Invest Dermatol 2014; 134: 2719–2727.
40. Zhou J, Shang J, Song J, et al. Interleukin-18 augments growth ability of primary human melanocytes by PTEN inactivation through the AKT/NF-kappaB pathway. Int J Biochem Cell Biol 2013; 45: 308–316.
41. Zhou J, Ping FF, Lv WT, et al. Interleukin-18 directly protects cortical neurons by activating PI3K/AKT/NF-kappaB/CREB pathways. Cytokine 2014; 69: 29–38.
42. Zhang J, Pan C, Xu T, et al. Interleukin 18 augments growth ability via NF-kappaB and p38/ATF2 pathways by targeting cyclin B1, cyclin B2, cyclin A2, and Bcl-2 in BRL-3A rat liver cells. Gene 2015; 563: 45–51.
43. Frank MG, Weber MD, Fonken LK, et al. The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome. Brain Behav Immun 2016; 55: 215–224.
44. Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-kappaB pathway in acute glaucoma. J Neuroinflammation 2015; 12: 137.
45. Walter A, Schafer M, Cecconi V, et al. Aldara activates TLR7-independent immune defence. Nat Commun 2013; 4: 1560.
46. Ma CH, Kang LL, Ren HM, et al. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-kappaB/NLRP3 inflammasome activation in high fructose-fed rats. J Ethnopharmacol 2015; 172: 108–117.
47. Garcia JA, Volt H, Venegas C, et al. Disruption of the NF-kappaB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-alpha and blocks the septic response in mice. FASEB J 2015; 29: 3863–3875.
48. Kawai K, Shimura H, Minagawa M, et al. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002; 30: 185–194.
49. Pivarcsi A, Bodai L, Rethi B, et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003; 15: 721–730.
50. Song PI, Park YM, Abraham T, et al. Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 2002; 119: 424–432.
51. He Q, You H, Li XM, et al. HMGB1 promotes the synthesis of pro-IL-1beta and pro-IL-18 by activation of p38 MAPK and NF-kappaB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev 2012; 13: 1365–1370.
52. Szomolanyi-Tsuda E, Liang X, Welsh RM, et al. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 2006; 80: 4286–4291.
53. Rhee AC, Cain AL, Hile KL, et al. IL-18 activation is dependent on Toll-like receptor 4 during renal obstruction. J Surg Res 2013; 183: 278–284.
54. Koch KN, Hartung ML, Urban S, et al. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Invest 2015; 125: 3297–3302.
55. Qi Y, Zhao M, Bai Y, et al. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes. Invest Ophthalmol Vis Sci 2014; 55: 5466–5475.
56. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–251.
57. Qin Y, Chen Y, Wang W, et al. HMGB1-LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotype. Cell Death Dis 2014; 5: e1077.
58. Schaper F, Westra J, Bijl M. Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus. Mol Med 2014; 20: 72–79.
59. Robinson AP, Caldis MW, Harp CT, et al. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. J Autoimmun 2013; 43: 32–43.
60. Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 2015; 43: 1040–1051.
61. Hirahara K, Nakayama T. CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol 2016; 28: 163–171.
62. Azizi G, Yazdani R, Mirshafiey A. Th22 cells in autoimmunity: a review of current knowledge. Eur Ann Allergy Clin Immunol 2015; 47: 108–117.
63. Su Z, Zhang P, Yu Y, et al. HMGB1 facilitated macrophage reprogramming towards a proinflammatory M1-like phenotype in experimental autoimmune myocarditis development. Sci Rep 2016; 6: 21884.
64. Ding JW, Zheng XX, Zhou T, et al. HMGB1 modulates the Treg/Th17 ratio in atherosclerotic patients. J Atheroscler Thromb 2016; 23: 737–745.
65. Guenova E, Skabytska Y, Hoetzenecker W, et al. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc Natl Acad Sci USA 2015; 112: 2163–2168.
66. Johnston A, Xing X, Swindell WR, et al. Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis. Hum Mol Genet 2013; 22: 1807–1815.